Contract Research Services
ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases.
As part of our ImQuest SUCCESS platform, we provide expert preclinical research services, including compound screening to define compound efficacy and drug target validation analysis to define the mechanism of action and toxicity of pharmaceutical products. We specialize in the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines for infectious disease and cancer drug development programs.
Our preclinical contract research services are comprised of interrelated efficacy-defining components for infectious disease (including microbiology and virology), cancer and women's health with parallel evaluations of in vitro and ex vivo toxicity and the pharmaceutical properties and chemical structure of preclinical candidates to efficiently validate you drug target.
We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in the field of virology, microbiology and oncology. As such, we understand that each product and each client is unique and we strive to provide effective solutions. Learn More.
Drug Resistant Bacteria are Reaching "Nightmare" Status
Contact us to learn more and discuss ways that we can help the world wake up from the nightmare of untreatable bacterial infections.
Cells vs. Pathogens: Intrinsic Defenses and Counterdefenses
March 23—26, 2018
Hyatt Regency Monterey, Monterey, California, USA
ImQuest on the Road in Raleigh-Durham
April 23rd - April 27th, 2018
Contact Us to Schedule a Meeting With Our Team